Effectiveness of intermittent oral iron therapy vs continuous oral iron therapy in treating iron deficieny anemia patients UpTo 5 year of age; randomized control trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20251128005

Enrollment

Registered

2025-11-28

Start date

2025-01-07

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron deficiency anemia Iron deficiency anemia, childrens

Interventions

Oral iron therapy daily with 6 mg /kg /day dosing for 3 months,Oral iron therapy on alternate day at dose of 6 mg /kg/day for 3 months

Active Comparator Drug,Experimental Drug

Continuous oral iron ferrous sulphate ,Intermittent oral ferrous sulphate

Eligibility

Sex/Gender

All

Age

1 Days to 5 Years

Inclusion criteria

Inclusion criteria: Patients of both genders with ages in the range of 0 -60 months suffering from IDA as per operational definition.

Exclusion criteria

Exclusion criteria: 1.Who have already taken treatment for IDA during last 2-months as per history/clinical record. 2.Who have undergone recent blood transfusion during last 12-weeks as per history/clinical record. 3.Children with chronic kidney disease, chronic liver disease, cardiac failure or concomitant malignancy

Design outcomes

Primary

Measure	Time frame
Hemoglobin level change 3 months g/dl	—

Secondary

Measure	Time frame
Ferritin level change 3 months ng/ml	—

Countries

Pakistan

Contacts

Public ContactMarryam Kaleem

UCHS lahore

marryamkaleem50@gmail.com923244320220

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026